HOME >> BIOLOGY >> NEWS
Seat of cellular bus system for protein passengers found by Dartmouth Medical School researchers

Hanover, NH For some proteins made deep within a cell, those that work elsewhere in the body have a complex journey aboard carrier vessels with many possible stops before they exit the cell and continue through the blood to reach their destination. Now Dartmouth Medical School biochemists have discovered a key receptor for sorting which proteins stay and which leave, documenting for the first time what many scientists theorized but had not confirmed about how proteins travel through cells for export.

Their results, published in the November 16 Science, help resolve a major piece of the cell traffic puzzle, paving the way for further understanding of how hormones such as insulin as well as other important factors are conveyed through cells for secretion into the blood stream. The authors are Charles Barlowe, PhD, associate professor of biochemistry and William J. Belden, a graduate student.

Transporting proteins that need to get out of the cell to function is essential. After they are manufactured on membranes in the cell interior, the proteins are captured in little vesicles that take them to the cell boundary to be discharged. Packaging the proteins to board the vesicles takes a series of steps not yet well delineated.

"Internal membranes have thousands of proteins in them and some of those proteins depend on vesicles to travel to another location. But the first step is getting it into a vesicle. Thats called sorting," says Barlowe.

He makes the analogy of a bus. "If there is a bus to carry passengers and the passengers need seats, then if we look at the bus carefully we should be able to find some seats." Barlowe, using bakers yeast as a model system, has found a seat on the cellular bus.

A popular cell transport model holds that a receptor will bind to a protein that needs to travel and capture it into the vesicle. However, no receptors that actually operate on this theory of selected transport had been found. Now
'"/>

Contact: Hali Wickner
Hali.Wickner@dartmouth.edu
603-650-1520
Dartmouth Medical School
15-Nov-2001


Page: 1 2 3

Related biology news :

1. New molecular link key to cellular proteins involved in cancer progression, other diseases
2. Israeli scientists reveal the plan of a key cellular machine
3. Unicellular organisms contribute more nitrogen to ocean that reported earlier
4. Scientists visualise cellular handmaiden that restores shape to proteins
5. Stroking up cellular therapy
6. Carnegie Mellon neuroscientist develops tool to image brain function at the cellular level
7. Molecular traffic cop directs cellular signals
8. University of Chicago scientists pinpoint cellular cause of SIDS
9. UCSD team determines cellular stress within body is critical
10. UNC scientists block cellular enzyme activity involved in cancer progression
11. HIV takes cellular opportunities to aid infection

Post Your Comments:
(Date:5/14/2015)... May 14, 2015  Verificient Technologies, Inc., ... and online remote proctoring, announced a new ... company and creator of the Canvas Learning ... two companies will benefit from the seamless ... As a fully integrated multifactor biometrics ...
(Date:5/11/2015)... Ohio , May 11, 2015  Through a well-rounded ... Ohio had a strong showing at AUVSI,s Unmanned ... These representatives of Ohio,s UAS industry ... and abroad from all points along the UAS ecosystem. ... Development Coalition,s (DDC) Vice President for Aerospace Rich Knoll ...
(Date:5/10/2015)... GOTHENBURG, Sweden , May 11, 2015 ... touch fingerprint sensors FPC1025 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... the sensors will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of + 1 000 ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2
(Date:5/21/2015)... Specialty Pharmacy Times has completed its ... BPA Worldwide as a business publication member. As ... for Specialty Pharmacy Times based on business/distribution, demographics ... member of BPA Worldwide, Specialty Pharmacy Times shows ... the most reliable, unequaled data,” said Chris Hennessy, ...
(Date:5/21/2015)... 21, 2015  The EveryLife Foundation for Rare ... and Amy Klobuchar (D-MN) today for ... & Treatments, or OPEN ACT. Supported ... organizations, this bipartisan legislation promises to rapidly bring ... rare disease patients by incentivizing drug makers to ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Veolia’s environmental monitoring technology division, ... distribution agreement with VWR to distribute TECTA™ B16, ... than 160 years of experience, VWR, a leading ... and production facilities, has cultivated a value proposition ... to enable science. Endetec’s TECTA™ B16, combines ...
Breaking Biology Technology:Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2
Cached News: